Review



fibroblast growth medium  (PromoCell)


Bioz Verified Symbol PromoCell is a verified supplier
Bioz Manufacturer Symbol PromoCell manufactures this product  
  • Logo
  • About
  • News
  • Press Release
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
  • 94

    Structured Review

    PromoCell fibroblast growth medium
    Characterisation of primary human peritoneal mesothelial cells (HPMCs) and human peritoneal fibroblasts (HPFs) compared to the LP-9 mesothelial cell line and normal human dermal fibroblasts (NHDFs). (A) Representative phase-contrast micrographs of LP-9, HPMCs, NHDFs and HPFs. Mesothelial and <t>fibroblast</t> cells exhibit cobblestone and spindle-like morphologies, respectively. (B) We observed localised expression of the cytoskeletal markers cytokeratin (CK) and vimentin (VIM) in LP-9 cells and HPMCs, while VIM, but not CK, was expressed in NHDFs and HPFs. HPMCs ( n =6) showed a high percentage of CK + /VIM + cells [98.20±1.05% (mean±s.d.)], while HPFs ( n =3) exhibited 81.36±5.63% CK − /VIM + cells. Scale bars: 200 µm (A); 50 µm (B).
    Fibroblast Growth Medium, supplied by PromoCell, used in various techniques. Bioz Stars score: 94/100, based on 12 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/fibroblast+medium+kit/Fibroblast+Growth+Medium+Kit/pmc12919959-165-4-7
    Average 94 stars, based on 12 article reviews
    fibroblast growth medium - by Bioz Stars, 2026-11
    94/100 stars

    Images

    1) Product Images from "Compound design of a patient-derived 3D cell culture system modelling early peritoneal endometriosis"

    Article Title: Compound design of a patient-derived 3D cell culture system modelling early peritoneal endometriosis

    Journal: Disease Models & Mechanisms

    doi: 10.1242/dmm.052436

    Characterisation of primary human peritoneal mesothelial cells (HPMCs) and human peritoneal fibroblasts (HPFs) compared to the LP-9 mesothelial cell line and normal human dermal fibroblasts (NHDFs). (A) Representative phase-contrast micrographs of LP-9, HPMCs, NHDFs and HPFs. Mesothelial and fibroblast cells exhibit cobblestone and spindle-like morphologies, respectively. (B) We observed localised expression of the cytoskeletal markers cytokeratin (CK) and vimentin (VIM) in LP-9 cells and HPMCs, while VIM, but not CK, was expressed in NHDFs and HPFs. HPMCs ( n =6) showed a high percentage of CK + /VIM + cells [98.20±1.05% (mean±s.d.)], while HPFs ( n =3) exhibited 81.36±5.63% CK − /VIM + cells. Scale bars: 200 µm (A); 50 µm (B).
    Figure Legend Snippet: Characterisation of primary human peritoneal mesothelial cells (HPMCs) and human peritoneal fibroblasts (HPFs) compared to the LP-9 mesothelial cell line and normal human dermal fibroblasts (NHDFs). (A) Representative phase-contrast micrographs of LP-9, HPMCs, NHDFs and HPFs. Mesothelial and fibroblast cells exhibit cobblestone and spindle-like morphologies, respectively. (B) We observed localised expression of the cytoskeletal markers cytokeratin (CK) and vimentin (VIM) in LP-9 cells and HPMCs, while VIM, but not CK, was expressed in NHDFs and HPFs. HPMCs ( n =6) showed a high percentage of CK + /VIM + cells [98.20±1.05% (mean±s.d.)], while HPFs ( n =3) exhibited 81.36±5.63% CK − /VIM + cells. Scale bars: 200 µm (A); 50 µm (B).

    Techniques Used: Expressing

    Establishing composite 3D hydrogel constructs using peritoneal mesothelial cells and fibroblasts. (A) Schematic illustration of model construction and culture timeline. (B) Representative axial view [also seen in C (M3)] and Haematoxylin and Eosin (H&E)-stained section of a hydrogel construct showing the formation of a mesothelial monolayer (ML) and submesothelial layer (SML) on a transwell membrane (TM). (C) Representative images of hydrogel matrices using M1 (collagen I), M2 (70:30 collagen I:Matrigel ratio), M3 (50:50 collagen I:Matrigel ratio) and M4 (collagen I+human fibronectin). Construct generated with matrix combination M3 demonstrated minimal contraction in LP-9/NHDF and HPMC/HPF trials. (D) Lactate dehydrogenase (LDH) cytotoxicity assay in M3 composite hydrogel constructs containing HPMC/HPF ( n =3 donors) over a 10-day culture period. (E) Dual immunofluorescence staining of cleaved caspase-3 (CC-3) and VIM to detect apoptotic HPMCs/HPFs in M3 constructs on day 3 and day 10 of culture ( n =3). Scale bars: 300 µm (B); 100 µm (C); 50 µm (E).
    Figure Legend Snippet: Establishing composite 3D hydrogel constructs using peritoneal mesothelial cells and fibroblasts. (A) Schematic illustration of model construction and culture timeline. (B) Representative axial view [also seen in C (M3)] and Haematoxylin and Eosin (H&E)-stained section of a hydrogel construct showing the formation of a mesothelial monolayer (ML) and submesothelial layer (SML) on a transwell membrane (TM). (C) Representative images of hydrogel matrices using M1 (collagen I), M2 (70:30 collagen I:Matrigel ratio), M3 (50:50 collagen I:Matrigel ratio) and M4 (collagen I+human fibronectin). Construct generated with matrix combination M3 demonstrated minimal contraction in LP-9/NHDF and HPMC/HPF trials. (D) Lactate dehydrogenase (LDH) cytotoxicity assay in M3 composite hydrogel constructs containing HPMC/HPF ( n =3 donors) over a 10-day culture period. (E) Dual immunofluorescence staining of cleaved caspase-3 (CC-3) and VIM to detect apoptotic HPMCs/HPFs in M3 constructs on day 3 and day 10 of culture ( n =3). Scale bars: 300 µm (B); 100 µm (C); 50 µm (E).

    Techniques Used: Construct, Staining, Membrane, Generated, LDH Cytotoxicity Assay, Immunofluorescence

    Histological and functional analysis of the human parietal peritoneum and peritoneal layer models. (A) Histological staining of transverse sections through parietal peritoneum and composite 3D hydrogel constructs composed of LP-9/NHDFs and HPMCs/HPFs. Immunofluorescence using antibodies against the mesothelial markers podoplanin (PDPN) and mesothelin (MSLN), and submesothelial markers fibroblast specific protein 1 (FSP1) and tumor endothelial marker 1 (TEM1). (B) Colocalisation of MSLN and collagen IV (COLIV) suggesting spontaneous basal lamina formation. (C) Human tissue plasminogen activator (tPA) enzyme-linked immunosorbent assay (ELISA) to determine the functionality of the mesothelial cells in models assembled with HPMCs from three different donors over a 10-day culture period. Scale bars: 50 µm; 15 µm (insets in B).
    Figure Legend Snippet: Histological and functional analysis of the human parietal peritoneum and peritoneal layer models. (A) Histological staining of transverse sections through parietal peritoneum and composite 3D hydrogel constructs composed of LP-9/NHDFs and HPMCs/HPFs. Immunofluorescence using antibodies against the mesothelial markers podoplanin (PDPN) and mesothelin (MSLN), and submesothelial markers fibroblast specific protein 1 (FSP1) and tumor endothelial marker 1 (TEM1). (B) Colocalisation of MSLN and collagen IV (COLIV) suggesting spontaneous basal lamina formation. (C) Human tissue plasminogen activator (tPA) enzyme-linked immunosorbent assay (ELISA) to determine the functionality of the mesothelial cells in models assembled with HPMCs from three different donors over a 10-day culture period. Scale bars: 50 µm; 15 µm (insets in B).

    Techniques Used: Functional Assay, Staining, Construct, Immunofluorescence, Marker, Enzyme-linked Immunosorbent Assay

    Related Articles

    Virus:

    Article Title: A 20-amino-acid Cardiovirus protein exhibits cytokine-mimicry activity to regulate viral replication.
    Article Snippet: .. REAGENT or RESOURCE SOURCE IDENTIFIER Antibodies Anti-GAPDH Santa Cruz Biotechnology Cat#: sc-32233; RRID: AB_627679 Anti-caspase-8 Cell Signaling Technology Cat#: 9746; RRID:AB_2275120 Anti-Cleaved PARP (Asp214) Cell Signaling Technology Cat#: 9541; RRID:AB_331426 Anti-3B (Anti-VPg EMCV ) This paper (Created by Immuno-Biological Laboratories Co., Ltd.) N/A (see Method Details) Anti-Mengo 3DPol Santa Cruz Biotechnology Cat#: sc-65633; RRID:AB_1565377 Anti-iNOS Santa Cruz Biotechnology Cat#: sc-7271; RRID:AB_627810 Anti-STAT1 Cell Signaling Technology Cat#: 9172; RRID:AB_2198300 Anti-pSTAT1 (Y701) Cell Signaling Technology Cat#: 9167; RRID:AB_561284 Anti-pSTAT2 (Y690) Cell Signaling Technology Cat#: 4441; RRID: AB_2198445 Anti-Myc-Tag Cell Signaling Technology Cat#: 2276; RRID: AB_331783 Anti-IκBα Santa Cruz Biotechnology Cat#: sc-371; RRID: AB_2235952 Anti-HSP70 Santa Cruz Biotechnology Cat#: sc-32239; RRID: AB_627759 Anti-IFNGR1 Proteintech Cat#: 10808-1-AP; RRID: AB_2121604 Anti-IFNGR2 Proteintech Cat#: 10266-1-AP; RRID: AB_2121709 Anti-mouse IgG, AP-linked (secondary antibody) Cell Signaling Technology Cat#: 7056; RRID:AB_330921 Anti-rabbit IgG, AP-linked (secondary antibody) Cell Signaling Technology Cat#: 7054; RRID: AB_2099235 Bacterial and virus strains Encephalomyocarditis virus (EMCV) ATCC Cat#: VR-129B Sendai Virus (SeV), strain Cantell ATCC Cat#: VR-907 Newcastle Disease Virus (NDV), strain Miyadera/51 Fujita et al., 1979 33 N/A Vesicular Stomatitis Virus (VSV), strain Indiana Oh et al., 2016 34 N/A Poliovirus (PV), strain type I Mahoney Shiroki et al., 1995 35 N/A Coxsackie Virus B3 (CVB3), strain Nancy Klump et al., 1990 36 N/A Enterovirus 71 (EV71), strain Isehara VP1145Q variant Kobayashi et al., 2018 37 N/A Competent high DH5α TOYOBO Cat#: DNA-903F Biological samples Human Dermal Fibroblasts, adult (HDFa) PromoCell Cat#: C-12302 Embryonated Chicken Eggs (9-day old) SHIMIZU Laboratory Supplies Co., Ltd. N/A Chemicals, peptides, and recombinant proteins Dulbecco’s Modified Eagle Medium (DMEM) Nacalai Tesque Inc. Cat#: 16971-55 Fetal bovine serum (FBS) Sigma-Aldrich Cat#: 173012 Antibiotic-Antimycotic Mixed Stock Solution Nacalai Tesque Inc. Cat#: 09366-44 Fibroblast Growth Medium 2 Kit PromoCell Cat#: C23020 Dulbecco’s Phosphate Buffered Saline (DPBS) Nacalai Tesque Inc. Cat#: 14249-24 4%-Paraformaldehyde Phosphate Buffer Solution (PFA) Nacalai Tesque Inc. Cat#: 09154-85 (Continued on next page) Cell Reports 45, 116740, January 27, 2026 17 .. REAGENT or RESOURCE SOURCE IDENTIFIER Deposited data RNA-seq data This paper GEO accession #: GSE286568 Experimental models: Cell lines HeLa ATCC Cat#: CCL-2; RRID: CVCL_0030 HeLa BAK/BAX DKO This paper N/A HeLa CASP8 KO This paper N/A HeLa IFNGR1 KO This paper N/A HeLa IFNGR2 KO This paper N/A HeLa IFNGR1/2 DKO This paper N/A HeLa TNFR1 KO This paper N/A A549 ATCC Cat#: CCL-185; RRID: CVCL_0023 RAW 264.7 ATCC Cat#: TIB-71; RRID: CVCL_0493 L929 ATCC Cat#: CCL-1; RRID: CVCL_0462 B16-F10 ATCC Cat#: CRL-6475; RRID: CVCL_0159 Vero ATCC Cat#: CCL-81; RRID: CVCL_0059 BHK-21 ATCC Cat#: CCL-10; RRID: CVCL_1914 HEK293T ATCC Cat#: CRL-3216; RRID: CVCL_0063 Experimental models: Organisms/strains C57BL/6 mice CLEA Japan, Inc. Cat#: C57BL/6JJcl Oligonucleotides See Table S3 for a complete list of oligonucleotides.

    Variant Assay:

    Article Title: A 20-amino-acid Cardiovirus protein exhibits cytokine-mimicry activity to regulate viral replication.
    Article Snippet: .. REAGENT or RESOURCE SOURCE IDENTIFIER Antibodies Anti-GAPDH Santa Cruz Biotechnology Cat#: sc-32233; RRID: AB_627679 Anti-caspase-8 Cell Signaling Technology Cat#: 9746; RRID:AB_2275120 Anti-Cleaved PARP (Asp214) Cell Signaling Technology Cat#: 9541; RRID:AB_331426 Anti-3B (Anti-VPg EMCV ) This paper (Created by Immuno-Biological Laboratories Co., Ltd.) N/A (see Method Details) Anti-Mengo 3DPol Santa Cruz Biotechnology Cat#: sc-65633; RRID:AB_1565377 Anti-iNOS Santa Cruz Biotechnology Cat#: sc-7271; RRID:AB_627810 Anti-STAT1 Cell Signaling Technology Cat#: 9172; RRID:AB_2198300 Anti-pSTAT1 (Y701) Cell Signaling Technology Cat#: 9167; RRID:AB_561284 Anti-pSTAT2 (Y690) Cell Signaling Technology Cat#: 4441; RRID: AB_2198445 Anti-Myc-Tag Cell Signaling Technology Cat#: 2276; RRID: AB_331783 Anti-IκBα Santa Cruz Biotechnology Cat#: sc-371; RRID: AB_2235952 Anti-HSP70 Santa Cruz Biotechnology Cat#: sc-32239; RRID: AB_627759 Anti-IFNGR1 Proteintech Cat#: 10808-1-AP; RRID: AB_2121604 Anti-IFNGR2 Proteintech Cat#: 10266-1-AP; RRID: AB_2121709 Anti-mouse IgG, AP-linked (secondary antibody) Cell Signaling Technology Cat#: 7056; RRID:AB_330921 Anti-rabbit IgG, AP-linked (secondary antibody) Cell Signaling Technology Cat#: 7054; RRID: AB_2099235 Bacterial and virus strains Encephalomyocarditis virus (EMCV) ATCC Cat#: VR-129B Sendai Virus (SeV), strain Cantell ATCC Cat#: VR-907 Newcastle Disease Virus (NDV), strain Miyadera/51 Fujita et al., 1979 33 N/A Vesicular Stomatitis Virus (VSV), strain Indiana Oh et al., 2016 34 N/A Poliovirus (PV), strain type I Mahoney Shiroki et al., 1995 35 N/A Coxsackie Virus B3 (CVB3), strain Nancy Klump et al., 1990 36 N/A Enterovirus 71 (EV71), strain Isehara VP1145Q variant Kobayashi et al., 2018 37 N/A Competent high DH5α TOYOBO Cat#: DNA-903F Biological samples Human Dermal Fibroblasts, adult (HDFa) PromoCell Cat#: C-12302 Embryonated Chicken Eggs (9-day old) SHIMIZU Laboratory Supplies Co., Ltd. N/A Chemicals, peptides, and recombinant proteins Dulbecco’s Modified Eagle Medium (DMEM) Nacalai Tesque Inc. Cat#: 16971-55 Fetal bovine serum (FBS) Sigma-Aldrich Cat#: 173012 Antibiotic-Antimycotic Mixed Stock Solution Nacalai Tesque Inc. Cat#: 09366-44 Fibroblast Growth Medium 2 Kit PromoCell Cat#: C23020 Dulbecco’s Phosphate Buffered Saline (DPBS) Nacalai Tesque Inc. Cat#: 14249-24 4%-Paraformaldehyde Phosphate Buffer Solution (PFA) Nacalai Tesque Inc. Cat#: 09154-85 (Continued on next page) Cell Reports 45, 116740, January 27, 2026 17 .. REAGENT or RESOURCE SOURCE IDENTIFIER Deposited data RNA-seq data This paper GEO accession #: GSE286568 Experimental models: Cell lines HeLa ATCC Cat#: CCL-2; RRID: CVCL_0030 HeLa BAK/BAX DKO This paper N/A HeLa CASP8 KO This paper N/A HeLa IFNGR1 KO This paper N/A HeLa IFNGR2 KO This paper N/A HeLa IFNGR1/2 DKO This paper N/A HeLa TNFR1 KO This paper N/A A549 ATCC Cat#: CCL-185; RRID: CVCL_0023 RAW 264.7 ATCC Cat#: TIB-71; RRID: CVCL_0493 L929 ATCC Cat#: CCL-1; RRID: CVCL_0462 B16-F10 ATCC Cat#: CRL-6475; RRID: CVCL_0159 Vero ATCC Cat#: CCL-81; RRID: CVCL_0059 BHK-21 ATCC Cat#: CCL-10; RRID: CVCL_1914 HEK293T ATCC Cat#: CRL-3216; RRID: CVCL_0063 Experimental models: Organisms/strains C57BL/6 mice CLEA Japan, Inc. Cat#: C57BL/6JJcl Oligonucleotides See Table S3 for a complete list of oligonucleotides.

    Recombinant:

    Article Title: A 20-amino-acid Cardiovirus protein exhibits cytokine-mimicry activity to regulate viral replication.
    Article Snippet: .. REAGENT or RESOURCE SOURCE IDENTIFIER Antibodies Anti-GAPDH Santa Cruz Biotechnology Cat#: sc-32233; RRID: AB_627679 Anti-caspase-8 Cell Signaling Technology Cat#: 9746; RRID:AB_2275120 Anti-Cleaved PARP (Asp214) Cell Signaling Technology Cat#: 9541; RRID:AB_331426 Anti-3B (Anti-VPg EMCV ) This paper (Created by Immuno-Biological Laboratories Co., Ltd.) N/A (see Method Details) Anti-Mengo 3DPol Santa Cruz Biotechnology Cat#: sc-65633; RRID:AB_1565377 Anti-iNOS Santa Cruz Biotechnology Cat#: sc-7271; RRID:AB_627810 Anti-STAT1 Cell Signaling Technology Cat#: 9172; RRID:AB_2198300 Anti-pSTAT1 (Y701) Cell Signaling Technology Cat#: 9167; RRID:AB_561284 Anti-pSTAT2 (Y690) Cell Signaling Technology Cat#: 4441; RRID: AB_2198445 Anti-Myc-Tag Cell Signaling Technology Cat#: 2276; RRID: AB_331783 Anti-IκBα Santa Cruz Biotechnology Cat#: sc-371; RRID: AB_2235952 Anti-HSP70 Santa Cruz Biotechnology Cat#: sc-32239; RRID: AB_627759 Anti-IFNGR1 Proteintech Cat#: 10808-1-AP; RRID: AB_2121604 Anti-IFNGR2 Proteintech Cat#: 10266-1-AP; RRID: AB_2121709 Anti-mouse IgG, AP-linked (secondary antibody) Cell Signaling Technology Cat#: 7056; RRID:AB_330921 Anti-rabbit IgG, AP-linked (secondary antibody) Cell Signaling Technology Cat#: 7054; RRID: AB_2099235 Bacterial and virus strains Encephalomyocarditis virus (EMCV) ATCC Cat#: VR-129B Sendai Virus (SeV), strain Cantell ATCC Cat#: VR-907 Newcastle Disease Virus (NDV), strain Miyadera/51 Fujita et al., 1979 33 N/A Vesicular Stomatitis Virus (VSV), strain Indiana Oh et al., 2016 34 N/A Poliovirus (PV), strain type I Mahoney Shiroki et al., 1995 35 N/A Coxsackie Virus B3 (CVB3), strain Nancy Klump et al., 1990 36 N/A Enterovirus 71 (EV71), strain Isehara VP1145Q variant Kobayashi et al., 2018 37 N/A Competent high DH5α TOYOBO Cat#: DNA-903F Biological samples Human Dermal Fibroblasts, adult (HDFa) PromoCell Cat#: C-12302 Embryonated Chicken Eggs (9-day old) SHIMIZU Laboratory Supplies Co., Ltd. N/A Chemicals, peptides, and recombinant proteins Dulbecco’s Modified Eagle Medium (DMEM) Nacalai Tesque Inc. Cat#: 16971-55 Fetal bovine serum (FBS) Sigma-Aldrich Cat#: 173012 Antibiotic-Antimycotic Mixed Stock Solution Nacalai Tesque Inc. Cat#: 09366-44 Fibroblast Growth Medium 2 Kit PromoCell Cat#: C23020 Dulbecco’s Phosphate Buffered Saline (DPBS) Nacalai Tesque Inc. Cat#: 14249-24 4%-Paraformaldehyde Phosphate Buffer Solution (PFA) Nacalai Tesque Inc. Cat#: 09154-85 (Continued on next page) Cell Reports 45, 116740, January 27, 2026 17 .. REAGENT or RESOURCE SOURCE IDENTIFIER Deposited data RNA-seq data This paper GEO accession #: GSE286568 Experimental models: Cell lines HeLa ATCC Cat#: CCL-2; RRID: CVCL_0030 HeLa BAK/BAX DKO This paper N/A HeLa CASP8 KO This paper N/A HeLa IFNGR1 KO This paper N/A HeLa IFNGR2 KO This paper N/A HeLa IFNGR1/2 DKO This paper N/A HeLa TNFR1 KO This paper N/A A549 ATCC Cat#: CCL-185; RRID: CVCL_0023 RAW 264.7 ATCC Cat#: TIB-71; RRID: CVCL_0493 L929 ATCC Cat#: CCL-1; RRID: CVCL_0462 B16-F10 ATCC Cat#: CRL-6475; RRID: CVCL_0159 Vero ATCC Cat#: CCL-81; RRID: CVCL_0059 BHK-21 ATCC Cat#: CCL-10; RRID: CVCL_1914 HEK293T ATCC Cat#: CRL-3216; RRID: CVCL_0063 Experimental models: Organisms/strains C57BL/6 mice CLEA Japan, Inc. Cat#: C57BL/6JJcl Oligonucleotides See Table S3 for a complete list of oligonucleotides.

    Article Title: Nanodiamond‐Based Quantum Sensing Reveals Changes in Endo‐Lysosomal Activity of Stimulated Cardiac Fibroblasts in a Cellular Fibrosis Model
    Article Snippet: .. Primary human cardiac fibroblasts (HCFs) (PromoCell, cat. no. C-23025) were cultured in an incubator under standard conditions of 5% CO2 and at 37◦C, in medium (PromoCell, cat. no. C-23130) containing Fetal Calf Serum (0.1 mL/ml), Basic Fibroblast Growth Factor (recombinant human, 1 ng/ml), Insulin (recombinant human, 5 μg/ml) and penicylin-streptamycin (1% v/v, ThermoFisher cat. no. 15140122). ..

    Article Title: Compound design of a patient-derived 3D cell culture system modelling early peritoneal endometriosis
    Article Snippet: NHDFs (C-12300) isolated from the dermis of juvenile foreskin were purchased from Promocell (Heidelberg, Germany). .. NHDFs were cultured in Fibroblast Growth Medium (Promocell, C-23110) containing 1 ng/ml recombinant human basic fibroblast growth factor and 5 μg/ml recombinant human insulin, supplemented with 2 mM L-glutamine and 100 μg/ml Primocin. ..

    Modification:

    Article Title: A 20-amino-acid Cardiovirus protein exhibits cytokine-mimicry activity to regulate viral replication.
    Article Snippet: .. REAGENT or RESOURCE SOURCE IDENTIFIER Antibodies Anti-GAPDH Santa Cruz Biotechnology Cat#: sc-32233; RRID: AB_627679 Anti-caspase-8 Cell Signaling Technology Cat#: 9746; RRID:AB_2275120 Anti-Cleaved PARP (Asp214) Cell Signaling Technology Cat#: 9541; RRID:AB_331426 Anti-3B (Anti-VPg EMCV ) This paper (Created by Immuno-Biological Laboratories Co., Ltd.) N/A (see Method Details) Anti-Mengo 3DPol Santa Cruz Biotechnology Cat#: sc-65633; RRID:AB_1565377 Anti-iNOS Santa Cruz Biotechnology Cat#: sc-7271; RRID:AB_627810 Anti-STAT1 Cell Signaling Technology Cat#: 9172; RRID:AB_2198300 Anti-pSTAT1 (Y701) Cell Signaling Technology Cat#: 9167; RRID:AB_561284 Anti-pSTAT2 (Y690) Cell Signaling Technology Cat#: 4441; RRID: AB_2198445 Anti-Myc-Tag Cell Signaling Technology Cat#: 2276; RRID: AB_331783 Anti-IκBα Santa Cruz Biotechnology Cat#: sc-371; RRID: AB_2235952 Anti-HSP70 Santa Cruz Biotechnology Cat#: sc-32239; RRID: AB_627759 Anti-IFNGR1 Proteintech Cat#: 10808-1-AP; RRID: AB_2121604 Anti-IFNGR2 Proteintech Cat#: 10266-1-AP; RRID: AB_2121709 Anti-mouse IgG, AP-linked (secondary antibody) Cell Signaling Technology Cat#: 7056; RRID:AB_330921 Anti-rabbit IgG, AP-linked (secondary antibody) Cell Signaling Technology Cat#: 7054; RRID: AB_2099235 Bacterial and virus strains Encephalomyocarditis virus (EMCV) ATCC Cat#: VR-129B Sendai Virus (SeV), strain Cantell ATCC Cat#: VR-907 Newcastle Disease Virus (NDV), strain Miyadera/51 Fujita et al., 1979 33 N/A Vesicular Stomatitis Virus (VSV), strain Indiana Oh et al., 2016 34 N/A Poliovirus (PV), strain type I Mahoney Shiroki et al., 1995 35 N/A Coxsackie Virus B3 (CVB3), strain Nancy Klump et al., 1990 36 N/A Enterovirus 71 (EV71), strain Isehara VP1145Q variant Kobayashi et al., 2018 37 N/A Competent high DH5α TOYOBO Cat#: DNA-903F Biological samples Human Dermal Fibroblasts, adult (HDFa) PromoCell Cat#: C-12302 Embryonated Chicken Eggs (9-day old) SHIMIZU Laboratory Supplies Co., Ltd. N/A Chemicals, peptides, and recombinant proteins Dulbecco’s Modified Eagle Medium (DMEM) Nacalai Tesque Inc. Cat#: 16971-55 Fetal bovine serum (FBS) Sigma-Aldrich Cat#: 173012 Antibiotic-Antimycotic Mixed Stock Solution Nacalai Tesque Inc. Cat#: 09366-44 Fibroblast Growth Medium 2 Kit PromoCell Cat#: C23020 Dulbecco’s Phosphate Buffered Saline (DPBS) Nacalai Tesque Inc. Cat#: 14249-24 4%-Paraformaldehyde Phosphate Buffer Solution (PFA) Nacalai Tesque Inc. Cat#: 09154-85 (Continued on next page) Cell Reports 45, 116740, January 27, 2026 17 .. REAGENT or RESOURCE SOURCE IDENTIFIER Deposited data RNA-seq data This paper GEO accession #: GSE286568 Experimental models: Cell lines HeLa ATCC Cat#: CCL-2; RRID: CVCL_0030 HeLa BAK/BAX DKO This paper N/A HeLa CASP8 KO This paper N/A HeLa IFNGR1 KO This paper N/A HeLa IFNGR2 KO This paper N/A HeLa IFNGR1/2 DKO This paper N/A HeLa TNFR1 KO This paper N/A A549 ATCC Cat#: CCL-185; RRID: CVCL_0023 RAW 264.7 ATCC Cat#: TIB-71; RRID: CVCL_0493 L929 ATCC Cat#: CCL-1; RRID: CVCL_0462 B16-F10 ATCC Cat#: CRL-6475; RRID: CVCL_0159 Vero ATCC Cat#: CCL-81; RRID: CVCL_0059 BHK-21 ATCC Cat#: CCL-10; RRID: CVCL_1914 HEK293T ATCC Cat#: CRL-3216; RRID: CVCL_0063 Experimental models: Organisms/strains C57BL/6 mice CLEA Japan, Inc. Cat#: C57BL/6JJcl Oligonucleotides See Table S3 for a complete list of oligonucleotides.

    Saline:

    Article Title: A 20-amino-acid Cardiovirus protein exhibits cytokine-mimicry activity to regulate viral replication.
    Article Snippet: .. REAGENT or RESOURCE SOURCE IDENTIFIER Antibodies Anti-GAPDH Santa Cruz Biotechnology Cat#: sc-32233; RRID: AB_627679 Anti-caspase-8 Cell Signaling Technology Cat#: 9746; RRID:AB_2275120 Anti-Cleaved PARP (Asp214) Cell Signaling Technology Cat#: 9541; RRID:AB_331426 Anti-3B (Anti-VPg EMCV ) This paper (Created by Immuno-Biological Laboratories Co., Ltd.) N/A (see Method Details) Anti-Mengo 3DPol Santa Cruz Biotechnology Cat#: sc-65633; RRID:AB_1565377 Anti-iNOS Santa Cruz Biotechnology Cat#: sc-7271; RRID:AB_627810 Anti-STAT1 Cell Signaling Technology Cat#: 9172; RRID:AB_2198300 Anti-pSTAT1 (Y701) Cell Signaling Technology Cat#: 9167; RRID:AB_561284 Anti-pSTAT2 (Y690) Cell Signaling Technology Cat#: 4441; RRID: AB_2198445 Anti-Myc-Tag Cell Signaling Technology Cat#: 2276; RRID: AB_331783 Anti-IκBα Santa Cruz Biotechnology Cat#: sc-371; RRID: AB_2235952 Anti-HSP70 Santa Cruz Biotechnology Cat#: sc-32239; RRID: AB_627759 Anti-IFNGR1 Proteintech Cat#: 10808-1-AP; RRID: AB_2121604 Anti-IFNGR2 Proteintech Cat#: 10266-1-AP; RRID: AB_2121709 Anti-mouse IgG, AP-linked (secondary antibody) Cell Signaling Technology Cat#: 7056; RRID:AB_330921 Anti-rabbit IgG, AP-linked (secondary antibody) Cell Signaling Technology Cat#: 7054; RRID: AB_2099235 Bacterial and virus strains Encephalomyocarditis virus (EMCV) ATCC Cat#: VR-129B Sendai Virus (SeV), strain Cantell ATCC Cat#: VR-907 Newcastle Disease Virus (NDV), strain Miyadera/51 Fujita et al., 1979 33 N/A Vesicular Stomatitis Virus (VSV), strain Indiana Oh et al., 2016 34 N/A Poliovirus (PV), strain type I Mahoney Shiroki et al., 1995 35 N/A Coxsackie Virus B3 (CVB3), strain Nancy Klump et al., 1990 36 N/A Enterovirus 71 (EV71), strain Isehara VP1145Q variant Kobayashi et al., 2018 37 N/A Competent high DH5α TOYOBO Cat#: DNA-903F Biological samples Human Dermal Fibroblasts, adult (HDFa) PromoCell Cat#: C-12302 Embryonated Chicken Eggs (9-day old) SHIMIZU Laboratory Supplies Co., Ltd. N/A Chemicals, peptides, and recombinant proteins Dulbecco’s Modified Eagle Medium (DMEM) Nacalai Tesque Inc. Cat#: 16971-55 Fetal bovine serum (FBS) Sigma-Aldrich Cat#: 173012 Antibiotic-Antimycotic Mixed Stock Solution Nacalai Tesque Inc. Cat#: 09366-44 Fibroblast Growth Medium 2 Kit PromoCell Cat#: C23020 Dulbecco’s Phosphate Buffered Saline (DPBS) Nacalai Tesque Inc. Cat#: 14249-24 4%-Paraformaldehyde Phosphate Buffer Solution (PFA) Nacalai Tesque Inc. Cat#: 09154-85 (Continued on next page) Cell Reports 45, 116740, January 27, 2026 17 .. REAGENT or RESOURCE SOURCE IDENTIFIER Deposited data RNA-seq data This paper GEO accession #: GSE286568 Experimental models: Cell lines HeLa ATCC Cat#: CCL-2; RRID: CVCL_0030 HeLa BAK/BAX DKO This paper N/A HeLa CASP8 KO This paper N/A HeLa IFNGR1 KO This paper N/A HeLa IFNGR2 KO This paper N/A HeLa IFNGR1/2 DKO This paper N/A HeLa TNFR1 KO This paper N/A A549 ATCC Cat#: CCL-185; RRID: CVCL_0023 RAW 264.7 ATCC Cat#: TIB-71; RRID: CVCL_0493 L929 ATCC Cat#: CCL-1; RRID: CVCL_0462 B16-F10 ATCC Cat#: CRL-6475; RRID: CVCL_0159 Vero ATCC Cat#: CCL-81; RRID: CVCL_0059 BHK-21 ATCC Cat#: CCL-10; RRID: CVCL_1914 HEK293T ATCC Cat#: CRL-3216; RRID: CVCL_0063 Experimental models: Organisms/strains C57BL/6 mice CLEA Japan, Inc. Cat#: C57BL/6JJcl Oligonucleotides See Table S3 for a complete list of oligonucleotides.

    Cell Culture:

    Article Title: Nanodiamond‐Based Quantum Sensing Reveals Changes in Endo‐Lysosomal Activity of Stimulated Cardiac Fibroblasts in a Cellular Fibrosis Model
    Article Snippet: .. Primary human cardiac fibroblasts (HCFs) (PromoCell, cat. no. C-23025) were cultured in an incubator under standard conditions of 5% CO2 and at 37◦C, in medium (PromoCell, cat. no. C-23130) containing Fetal Calf Serum (0.1 mL/ml), Basic Fibroblast Growth Factor (recombinant human, 1 ng/ml), Insulin (recombinant human, 5 μg/ml) and penicylin-streptamycin (1% v/v, ThermoFisher cat. no. 15140122). ..

    Article Title: A 20-amino-acid Cardiovirus protein exhibits cytokine-mimicry activity to regulate viral replication.
    Article Snippet: HeLa cells (ATCC, CCL-2), A549 cells (ATCC, CCL-185), RAW 264.7 cells (ATCC, TIB-71), L929 cells (ATCC, CCL-1), B16-F10 cells (ATCC, CRL-6475), Vero cells (ATCC, CCL-81), BHK-21 cells (ATCC, CCL-10), and HEK293T cells (ATCC, CRL-3216) were cultured in DMEM medium (Nacalai Tesque Inc., 16971-55) supplied with 10% FBS (Sigma-Aldrich, 173012) and 1% Antibiotic-Antimycotic Mixed Stock Solution (Nacalai Tesque Inc., 09366-44). .. Human Dermal Fibroblasts, Adult (HDFa, PromoCell, C-12302) were cultured in Fibroblast Basal Medium 2 (PromoCell, C23220) contained in the Fibroblast Growth Medium 2 Kit (PromoCell, C23020), in which the medium was prepared using the manufacturer’s instructions. ..

    Article Title: Label-free mid-infrared dichroism-sensitive photoacoustic microscopy for histostructural analysis of engineered heart tissues
    Article Snippet: .. Human cardiac fibroblasts (CFs; C-12375, PromoCell) were cultured in Fibroblast Growth Medium (C-23130, PromoCell) and passaged every 2–3 days. ..

    Article Title: Label-free mid-infrared dichroism-sensitive photoacoustic microscopy for histostructural analysis of engineered heart tissues.
    Article Snippet: .. Human cardiac fibroblasts (CFs; C-12375, PromoCell) were cultured in Fibroblast Growth Medium (C-23130, PromoCell) and passaged every 2–3 days. ..

    Article Title: Sushi, von Willebrand Factor Type A, EGF and Pentraxin Domain‐Containing Protein 1: A Novel Fibroblast‐Derived Circulating Biomarker Reflecting Cardiac Fibrosis
    Article Snippet: .. Human cardiac fibroblasts (HCFs) isolated from the ventricles of adult hearts were purchased from Promocell (#C- 12375) and cultured in fibroblast growth medium (Promocell, #C- 23110) supplemented with 10% fetal bovine serum, penicillin–streptomycin, and insulin at 37 °C and 5% CO2. ..

    Article Title: Compound design of a patient-derived 3D cell culture system modelling early peritoneal endometriosis
    Article Snippet: NHDFs (C-12300) isolated from the dermis of juvenile foreskin were purchased from Promocell (Heidelberg, Germany). .. NHDFs were cultured in Fibroblast Growth Medium (Promocell, C-23110) containing 1 ng/ml recombinant human basic fibroblast growth factor and 5 μg/ml recombinant human insulin, supplemented with 2 mM L-glutamine and 100 μg/ml Primocin. ..

    Activation Assay:

    Article Title: Efficient multi-lineage cardiovascular differentiation of human pluripotent stem cells in animal serum-free conditions
    Article Snippet: Cardiac fibroblast differentiation was adapted from Zhang et al. with replacement of FCS by Panexin (PAN Biotech, #P04-95750P). .. Following WNT activation and inhibition phases, cells were replated and matured in fibroblast growth medium (FGM, PromoCell #C-23130) supplemented with Panexin (replacing fetal calf serum), 10 ng/ml FGF2 and 10 μM SB431542, where indicated. ..

    Inhibition:

    Article Title: Efficient multi-lineage cardiovascular differentiation of human pluripotent stem cells in animal serum-free conditions
    Article Snippet: Cardiac fibroblast differentiation was adapted from Zhang et al. with replacement of FCS by Panexin (PAN Biotech, #P04-95750P). .. Following WNT activation and inhibition phases, cells were replated and matured in fibroblast growth medium (FGM, PromoCell #C-23130) supplemented with Panexin (replacing fetal calf serum), 10 ng/ml FGF2 and 10 μM SB431542, where indicated. ..

    Isolation:

    Article Title: Sushi, von Willebrand Factor Type A, EGF and Pentraxin Domain‐Containing Protein 1: A Novel Fibroblast‐Derived Circulating Biomarker Reflecting Cardiac Fibrosis
    Article Snippet: .. Human cardiac fibroblasts (HCFs) isolated from the ventricles of adult hearts were purchased from Promocell (#C- 12375) and cultured in fibroblast growth medium (Promocell, #C- 23110) supplemented with 10% fetal bovine serum, penicillin–streptomycin, and insulin at 37 °C and 5% CO2. ..



    Similar Products

    93
    Innoprot Inc fibroblast medium fm innoprot p60108 human il 6 duoset elisa bio techne dy206 05 r d human il 8 cxcl8
    Fibroblast Medium Fm Innoprot P60108 Human Il 6 Duoset Elisa Bio Techne Dy206 05 R D Human Il 8 Cxcl8, supplied by Innoprot Inc, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/fibroblast+medium+kit/Fibroblast+Medium+Kit/pm42291238-304-137-140
    Average 93 stars, based on 1 article reviews
    fibroblast medium fm innoprot p60108 human il 6 duoset elisa bio techne dy206 05 r d human il 8 cxcl8 - by Bioz Stars, 2026-11
    93/100 stars
      Buy from Supplier

    94
    PromoCell fibroblast growth medium
    Characterisation of primary human peritoneal mesothelial cells (HPMCs) and human peritoneal fibroblasts (HPFs) compared to the LP-9 mesothelial cell line and normal human dermal fibroblasts (NHDFs). (A) Representative phase-contrast micrographs of LP-9, HPMCs, NHDFs and HPFs. Mesothelial and <t>fibroblast</t> cells exhibit cobblestone and spindle-like morphologies, respectively. (B) We observed localised expression of the cytoskeletal markers cytokeratin (CK) and vimentin (VIM) in LP-9 cells and HPMCs, while VIM, but not CK, was expressed in NHDFs and HPFs. HPMCs ( n =6) showed a high percentage of CK + /VIM + cells [98.20±1.05% (mean±s.d.)], while HPFs ( n =3) exhibited 81.36±5.63% CK − /VIM + cells. Scale bars: 200 µm (A); 50 µm (B).
    Fibroblast Growth Medium, supplied by PromoCell, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/fibroblast+medium+kit/Fibroblast+Growth+Medium+Kit/pmc12919959-165-4-7
    Average 94 stars, based on 1 article reviews
    fibroblast growth medium - by Bioz Stars, 2026-11
    94/100 stars
      Buy from Supplier

    96
    ATCC f 12k medium
    Characterisation of primary human peritoneal mesothelial cells (HPMCs) and human peritoneal fibroblasts (HPFs) compared to the LP-9 mesothelial cell line and normal human dermal fibroblasts (NHDFs). (A) Representative phase-contrast micrographs of LP-9, HPMCs, NHDFs and HPFs. Mesothelial and <t>fibroblast</t> cells exhibit cobblestone and spindle-like morphologies, respectively. (B) We observed localised expression of the cytoskeletal markers cytokeratin (CK) and vimentin (VIM) in LP-9 cells and HPMCs, while VIM, but not CK, was expressed in NHDFs and HPFs. HPMCs ( n =6) showed a high percentage of CK + /VIM + cells [98.20±1.05% (mean±s.d.)], while HPFs ( n =3) exhibited 81.36±5.63% CK − /VIM + cells. Scale bars: 200 µm (A); 50 µm (B).
    F 12k Medium, supplied by ATCC, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/fibroblast+medium+kit/Fibroblast+Growth+Kit-Low+serum/10__13052_slash_ijts2246___8765__2026__006-95-24-32
    Average 96 stars, based on 1 article reviews
    f 12k medium - by Bioz Stars, 2026-11
    96/100 stars
      Buy from Supplier

    96
    ATCC fibroblast basal medium plus fibroblast growth kitlow serum
    Characterisation of primary human peritoneal mesothelial cells (HPMCs) and human peritoneal fibroblasts (HPFs) compared to the LP-9 mesothelial cell line and normal human dermal fibroblasts (NHDFs). (A) Representative phase-contrast micrographs of LP-9, HPMCs, NHDFs and HPFs. Mesothelial and <t>fibroblast</t> cells exhibit cobblestone and spindle-like morphologies, respectively. (B) We observed localised expression of the cytoskeletal markers cytokeratin (CK) and vimentin (VIM) in LP-9 cells and HPMCs, while VIM, but not CK, was expressed in NHDFs and HPFs. HPMCs ( n =6) showed a high percentage of CK + /VIM + cells [98.20±1.05% (mean±s.d.)], while HPFs ( n =3) exhibited 81.36±5.63% CK − /VIM + cells. Scale bars: 200 µm (A); 50 µm (B).
    Fibroblast Basal Medium Plus Fibroblast Growth Kitlow Serum, supplied by ATCC, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/fibroblast+medium+kit/Fibroblast+Growth+Kit-Low+serum/pm42276073-414-8-16
    Average 96 stars, based on 1 article reviews
    fibroblast basal medium plus fibroblast growth kitlow serum - by Bioz Stars, 2026-11
    96/100 stars
      Buy from Supplier

    94
    PromoCell fetal bovine serum
    Characterisation of primary human peritoneal mesothelial cells (HPMCs) and human peritoneal fibroblasts (HPFs) compared to the LP-9 mesothelial cell line and normal human dermal fibroblasts (NHDFs). (A) Representative phase-contrast micrographs of LP-9, HPMCs, NHDFs and HPFs. Mesothelial and <t>fibroblast</t> cells exhibit cobblestone and spindle-like morphologies, respectively. (B) We observed localised expression of the cytoskeletal markers cytokeratin (CK) and vimentin (VIM) in LP-9 cells and HPMCs, while VIM, but not CK, was expressed in NHDFs and HPFs. HPMCs ( n =6) showed a high percentage of CK + /VIM + cells [98.20±1.05% (mean±s.d.)], while HPFs ( n =3) exhibited 81.36±5.63% CK − /VIM + cells. Scale bars: 200 µm (A); 50 µm (B).
    Fetal Bovine Serum, supplied by PromoCell, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/fibroblast+medium+kit/Fibroblast+Growth+Medium+Kit/10__1161_slash_jaha__125__047119-60-29-23
    Average 94 stars, based on 1 article reviews
    fetal bovine serum - by Bioz Stars, 2026-11
    94/100 stars
      Buy from Supplier

    86
    Lifeline Cell Technology fibrolife s2 fibroblast medium complete kit lifeline cell technology ll 0011
    Characterisation of primary human peritoneal mesothelial cells (HPMCs) and human peritoneal fibroblasts (HPFs) compared to the LP-9 mesothelial cell line and normal human dermal fibroblasts (NHDFs). (A) Representative phase-contrast micrographs of LP-9, HPMCs, NHDFs and HPFs. Mesothelial and <t>fibroblast</t> cells exhibit cobblestone and spindle-like morphologies, respectively. (B) We observed localised expression of the cytoskeletal markers cytokeratin (CK) and vimentin (VIM) in LP-9 cells and HPMCs, while VIM, but not CK, was expressed in NHDFs and HPFs. HPMCs ( n =6) showed a high percentage of CK + /VIM + cells [98.20±1.05% (mean±s.d.)], while HPFs ( n =3) exhibited 81.36±5.63% CK − /VIM + cells. Scale bars: 200 µm (A); 50 µm (B).
    Fibrolife S2 Fibroblast Medium Complete Kit Lifeline Cell Technology Ll 0011, supplied by Lifeline Cell Technology, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/fibroblast+medium+kit/0011+cell+lifeline+ll+technology/pmc13149334-308-20-6
    Average 86 stars, based on 1 article reviews
    fibrolife s2 fibroblast medium complete kit lifeline cell technology ll 0011 - by Bioz Stars, 2026-11
    86/100 stars
      Buy from Supplier

    93
    Innoprot Inc fibroblast medium kit
    Characterisation of primary human peritoneal mesothelial cells (HPMCs) and human peritoneal fibroblasts (HPFs) compared to the LP-9 mesothelial cell line and normal human dermal fibroblasts (NHDFs). (A) Representative phase-contrast micrographs of LP-9, HPMCs, NHDFs and HPFs. Mesothelial and <t>fibroblast</t> cells exhibit cobblestone and spindle-like morphologies, respectively. (B) We observed localised expression of the cytoskeletal markers cytokeratin (CK) and vimentin (VIM) in LP-9 cells and HPMCs, while VIM, but not CK, was expressed in NHDFs and HPFs. HPMCs ( n =6) showed a high percentage of CK + /VIM + cells [98.20±1.05% (mean±s.d.)], while HPFs ( n =3) exhibited 81.36±5.63% CK − /VIM + cells. Scale bars: 200 µm (A); 50 µm (B).
    Fibroblast Medium Kit, supplied by Innoprot Inc, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/fibroblast+medium+kit/Fibroblast+Medium+Kit/pm41910429-46-29-32
    Average 93 stars, based on 1 article reviews
    fibroblast medium kit - by Bioz Stars, 2026-11
    93/100 stars
      Buy from Supplier

    93
    Innoprot Inc fibroblast medium
    Characterisation of primary human peritoneal mesothelial cells (HPMCs) and human peritoneal fibroblasts (HPFs) compared to the LP-9 mesothelial cell line and normal human dermal fibroblasts (NHDFs). (A) Representative phase-contrast micrographs of LP-9, HPMCs, NHDFs and HPFs. Mesothelial and <t>fibroblast</t> cells exhibit cobblestone and spindle-like morphologies, respectively. (B) We observed localised expression of the cytoskeletal markers cytokeratin (CK) and vimentin (VIM) in LP-9 cells and HPMCs, while VIM, but not CK, was expressed in NHDFs and HPFs. HPMCs ( n =6) showed a high percentage of CK + /VIM + cells [98.20±1.05% (mean±s.d.)], while HPFs ( n =3) exhibited 81.36±5.63% CK − /VIM + cells. Scale bars: 200 µm (A); 50 µm (B).
    Fibroblast Medium, supplied by Innoprot Inc, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/fibroblast+medium+kit/Fibroblast+Medium+Kit/pm41708343-49-16-19
    Average 93 stars, based on 1 article reviews
    fibroblast medium - by Bioz Stars, 2026-11
    93/100 stars
      Buy from Supplier

    Image Search Results


    Characterisation of primary human peritoneal mesothelial cells (HPMCs) and human peritoneal fibroblasts (HPFs) compared to the LP-9 mesothelial cell line and normal human dermal fibroblasts (NHDFs). (A) Representative phase-contrast micrographs of LP-9, HPMCs, NHDFs and HPFs. Mesothelial and fibroblast cells exhibit cobblestone and spindle-like morphologies, respectively. (B) We observed localised expression of the cytoskeletal markers cytokeratin (CK) and vimentin (VIM) in LP-9 cells and HPMCs, while VIM, but not CK, was expressed in NHDFs and HPFs. HPMCs ( n =6) showed a high percentage of CK + /VIM + cells [98.20±1.05% (mean±s.d.)], while HPFs ( n =3) exhibited 81.36±5.63% CK − /VIM + cells. Scale bars: 200 µm (A); 50 µm (B).

    Journal: Disease Models & Mechanisms

    Article Title: Compound design of a patient-derived 3D cell culture system modelling early peritoneal endometriosis

    doi: 10.1242/dmm.052436

    Figure Lengend Snippet: Characterisation of primary human peritoneal mesothelial cells (HPMCs) and human peritoneal fibroblasts (HPFs) compared to the LP-9 mesothelial cell line and normal human dermal fibroblasts (NHDFs). (A) Representative phase-contrast micrographs of LP-9, HPMCs, NHDFs and HPFs. Mesothelial and fibroblast cells exhibit cobblestone and spindle-like morphologies, respectively. (B) We observed localised expression of the cytoskeletal markers cytokeratin (CK) and vimentin (VIM) in LP-9 cells and HPMCs, while VIM, but not CK, was expressed in NHDFs and HPFs. HPMCs ( n =6) showed a high percentage of CK + /VIM + cells [98.20±1.05% (mean±s.d.)], while HPFs ( n =3) exhibited 81.36±5.63% CK − /VIM + cells. Scale bars: 200 µm (A); 50 µm (B).

    Article Snippet: NHDFs were cultured in Fibroblast Growth Medium (Promocell, C-23110) containing 1 ng/ml recombinant human basic fibroblast growth factor and 5 μg/ml recombinant human insulin, supplemented with 2 mM L-glutamine and 100 μg/ml Primocin.

    Techniques: Expressing

    Establishing composite 3D hydrogel constructs using peritoneal mesothelial cells and fibroblasts. (A) Schematic illustration of model construction and culture timeline. (B) Representative axial view [also seen in C (M3)] and Haematoxylin and Eosin (H&E)-stained section of a hydrogel construct showing the formation of a mesothelial monolayer (ML) and submesothelial layer (SML) on a transwell membrane (TM). (C) Representative images of hydrogel matrices using M1 (collagen I), M2 (70:30 collagen I:Matrigel ratio), M3 (50:50 collagen I:Matrigel ratio) and M4 (collagen I+human fibronectin). Construct generated with matrix combination M3 demonstrated minimal contraction in LP-9/NHDF and HPMC/HPF trials. (D) Lactate dehydrogenase (LDH) cytotoxicity assay in M3 composite hydrogel constructs containing HPMC/HPF ( n =3 donors) over a 10-day culture period. (E) Dual immunofluorescence staining of cleaved caspase-3 (CC-3) and VIM to detect apoptotic HPMCs/HPFs in M3 constructs on day 3 and day 10 of culture ( n =3). Scale bars: 300 µm (B); 100 µm (C); 50 µm (E).

    Journal: Disease Models & Mechanisms

    Article Title: Compound design of a patient-derived 3D cell culture system modelling early peritoneal endometriosis

    doi: 10.1242/dmm.052436

    Figure Lengend Snippet: Establishing composite 3D hydrogel constructs using peritoneal mesothelial cells and fibroblasts. (A) Schematic illustration of model construction and culture timeline. (B) Representative axial view [also seen in C (M3)] and Haematoxylin and Eosin (H&E)-stained section of a hydrogel construct showing the formation of a mesothelial monolayer (ML) and submesothelial layer (SML) on a transwell membrane (TM). (C) Representative images of hydrogel matrices using M1 (collagen I), M2 (70:30 collagen I:Matrigel ratio), M3 (50:50 collagen I:Matrigel ratio) and M4 (collagen I+human fibronectin). Construct generated with matrix combination M3 demonstrated minimal contraction in LP-9/NHDF and HPMC/HPF trials. (D) Lactate dehydrogenase (LDH) cytotoxicity assay in M3 composite hydrogel constructs containing HPMC/HPF ( n =3 donors) over a 10-day culture period. (E) Dual immunofluorescence staining of cleaved caspase-3 (CC-3) and VIM to detect apoptotic HPMCs/HPFs in M3 constructs on day 3 and day 10 of culture ( n =3). Scale bars: 300 µm (B); 100 µm (C); 50 µm (E).

    Article Snippet: NHDFs were cultured in Fibroblast Growth Medium (Promocell, C-23110) containing 1 ng/ml recombinant human basic fibroblast growth factor and 5 μg/ml recombinant human insulin, supplemented with 2 mM L-glutamine and 100 μg/ml Primocin.

    Techniques: Construct, Staining, Membrane, Generated, LDH Cytotoxicity Assay, Immunofluorescence

    Histological and functional analysis of the human parietal peritoneum and peritoneal layer models. (A) Histological staining of transverse sections through parietal peritoneum and composite 3D hydrogel constructs composed of LP-9/NHDFs and HPMCs/HPFs. Immunofluorescence using antibodies against the mesothelial markers podoplanin (PDPN) and mesothelin (MSLN), and submesothelial markers fibroblast specific protein 1 (FSP1) and tumor endothelial marker 1 (TEM1). (B) Colocalisation of MSLN and collagen IV (COLIV) suggesting spontaneous basal lamina formation. (C) Human tissue plasminogen activator (tPA) enzyme-linked immunosorbent assay (ELISA) to determine the functionality of the mesothelial cells in models assembled with HPMCs from three different donors over a 10-day culture period. Scale bars: 50 µm; 15 µm (insets in B).

    Journal: Disease Models & Mechanisms

    Article Title: Compound design of a patient-derived 3D cell culture system modelling early peritoneal endometriosis

    doi: 10.1242/dmm.052436

    Figure Lengend Snippet: Histological and functional analysis of the human parietal peritoneum and peritoneal layer models. (A) Histological staining of transverse sections through parietal peritoneum and composite 3D hydrogel constructs composed of LP-9/NHDFs and HPMCs/HPFs. Immunofluorescence using antibodies against the mesothelial markers podoplanin (PDPN) and mesothelin (MSLN), and submesothelial markers fibroblast specific protein 1 (FSP1) and tumor endothelial marker 1 (TEM1). (B) Colocalisation of MSLN and collagen IV (COLIV) suggesting spontaneous basal lamina formation. (C) Human tissue plasminogen activator (tPA) enzyme-linked immunosorbent assay (ELISA) to determine the functionality of the mesothelial cells in models assembled with HPMCs from three different donors over a 10-day culture period. Scale bars: 50 µm; 15 µm (insets in B).

    Article Snippet: NHDFs were cultured in Fibroblast Growth Medium (Promocell, C-23110) containing 1 ng/ml recombinant human basic fibroblast growth factor and 5 μg/ml recombinant human insulin, supplemented with 2 mM L-glutamine and 100 μg/ml Primocin.

    Techniques: Functional Assay, Staining, Construct, Immunofluorescence, Marker, Enzyme-linked Immunosorbent Assay